Partnering with the NCOMS provides significant value to pharmaceutical companies operating in the oncology space. In addition to direct access to oncology industry leaders across the state, these companies stay on the forefront of clinical, operational, and legislative updates critical to oncology practices and systems across the state. This wealth of insights from frontline oncology managers and administrators is invaluable to ensuring product and priority alignment with your company’s offering and goals.

NCOMS also has a Vendor Advisory Council (VAC)  comprised of a rotating group of pharmaceutical leaders to ensure alignment across NCOMS and industry and maximize our collective impact on improving the delivery of cancer care services in North Carolina. Our 2023-2024 VAC is comprised of representatives from Astrazeneca, AmeriSource Bergen, Bristol Myers Squibb, Exelixis, and GSK. Interested in joining next years VAC? Let’s talk!